AssetMark Inc’s Replimune Group REPL Stock Holding History

AssetMark Inc’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.67K	Buy	+202	New	+$2.55K	﹤0.01%	2962

Other funds holding REPL

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

AssetMark Inc's REPL Position: Q3 2026 in Review

AssetMark Inc opened a new position in Replimune Group (REPL) in Q3 2026: 202 shares worth $2.67K. The stake represents ﹤0.01% of the portfolio and ranks #2962 among its holdings.

19 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

AssetMark Inc held 202 shares of Replimune Group worth $2.67K as of Q3 2026.
Replimune Group was a new AssetMark Inc position in Q3 2026.
Replimune Group made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2962 holding.
19 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.